Ocular inserts for controlled delivery of pefloxacin mesylate: Preparation and evaluation

Acta Pharmaceutica

Volumn 55, Issue 3, 2005, Pages 305-314

  Sultana, Yasmin ^a   Aqil, Mohammad ^a   Ali, Asgar ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

In vitro release studies; In vivo studies; Ocular insert; Pefloxacin mesylate

Indexed keywords

EUDRAGIT; EUDRAGIT RS; PEFLOXACIN MESILATE; PHTHALIC ACID DIBUTYL ESTER; PLASTICIZER; POLITEF; POLYMER; POVIDONE; PROPYLENE GLYCOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONJUNCTIVITIS; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; FLOW; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; RABBIT; TECHNIQUE;

EID: 27144492980     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. R. D. Schoenwald, Ocular drug delivery, pharmacokinetic considerations, Clin. Pharmacokinet. 18 (1998) 255-269.
2. V. H. L. Lee, Precorneal, Corneal and Postcorneal Factors, in Drugs and Pharmaceutical Sciences (Ed. J. Swarbrick), Vol 58, Marcel Dekker Inc., New York 1993, pp. 59-81.
3. V. H. L. Lee and J. R. Robinson, Topical ocular drug delivery: recent developments and future challenges, J. Ocul. Pharmacol. 2 (1986) 67-108.
4. 3H] dexamethasone ophthalmic film delivery systems in the rabbit eye, Int. J. Pharm. 47 (1988) 21-30.
5. S. Barath and S. R. Hiremath, Ocular delivery system of pefloxacin mesylate, Pharmazie 54 (1999) 55-58.
6. L. R. Hume, H. K. Lee, L. Benedetti, Y. D. Sanzgiri, E. M. Topp and V. J. Stella, Ocular sustained delivery of prednisolone using hyaluronic acid benzyl ester films, Int. J. Pharm. 111 (1994) 295-298.
7. G. M. Grass, J. Cobby and M. C. Makoid, Ocular delivery of pilocarpine from erodible matrices, J. Pharm. Sci. 73 (1984) 618-621.
8. Y. F. Maichuk, Ophthalmic drug inserts, Invest. Ophthalmol. 14 (1975) 87-90.
9. H. Ozawa, S. Hosaka, T. Kunitomo and H. Tanzawa, Ocular inserts for controlled release of antibiotics, Biomaterials. 4 (1984) 170-174.
10. V. Baeyens, O. Felt-Baeyens, S. Rougier, S. Pheulpin, B. Boisrame and R. Gurny, Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) for the treatment of external ocular infections in dogs, J. Control. Rel. 85 (2002) 163-168.
11. H. Sasaki, T. Nagano, K. Sakanaka, S. Kawakami, K. Nishida, J. Nakamura, N. Ichikawa, J. Iwashita, T. Nakamura and M. Nakashima, One-side-coated insert as a unique ophthalmic drug delivery system, J. Control Rel. 92 (2003) 241-247.
12. A. Ali and S. N. Sharma, Cromolyn sodium in the treatment of allergic conjunctivitis caused by congress grass, Ind. J. Hosp. Pharm. 28 (1991) 165-169.
13. British Pharmacopoeia, Stationery Office, London 2000.
14. J. B. Schwartz, A. P. Simonelli and W. I. Higuchi, Drug release from wax matrices. I. Analysis of data with first order kinetics and with the diffusion controlled model, J. Pharm. Sci. 57 (1968) 274-277.
15. Guidance for Industry - Q1A(R2) Stability Testing of New Drug Substances and Products, ICH November 2003, Revison 2 FDA Rockville MD; http://www.fda.gov/cder/guidance/5635fnl.pdf; accessed May 30, 2005.
16. S. K. El-Arini and H. Leuenberger, Modelling of drug release from polymer matrices: Effect of drug loading, Int. J. Pharm. 121 (1995) 141-148.
17. R. W. Korsmeyer, R. Gurny, E. Doelkar, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35.
18. P. Costa, J. M. S. Lobo, Modelling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133.